Expression of TIGIT and FCRL3 is Altered in T Cells from Patients with Distinct Patterns of Chronic Autoimmune Thyroiditis

Abstract

Background Co-inhibitory receptors (IR), such as TIGIT and FCRL3, provide a checkpoint against highly destructive immune responses. Co-expression of TIGIT and FCRL3, in particular, has been linked to the HELIOS⁺ subset of regulatory CD4⁺FOXP3⁺T-cells. Of these, CD4⁺FOXP3-exon(E)2⁺ cells have higher expression of IR and exhibit strongest suppressive properties. Nevertheless, how the expression of TIGIT, FCRL3, HELIOS, and FOXP3E2 is regulated in chronic autoimmune thyroiditis (AT), is not known.

Methods Thirty patients with AT [encompassing spontaneously euthyroid (euAT), hypothyroid-untreated and L-thyroxine-treated cases)] and 10 healthy controls (HC) were recruited. FCRL3, TIGIT, HELIOS and FOXP3E2 mRNA expression levels in peripheral blood (PB) T cells were measured via quantitative real-time PCR and compared to clinicopathological factors.

Results The TIGIT and FCRL3 expression levels from T cells of AT cases were inversely related to the thyroid volume, and were significantly increased in hypothyroid patients (on+off L-thyroxine), but not euAT cases. The FCRL3 expression in PB T cells positively correlated with thyroid-peroxidase autoantibody levels; by contrast, T cells from aged AT patients and combined samples (AT+HC) accumulated more TIGIT mRNA. The patients with higher TIGIT mRNA levels had a greater prevalence of hypothyroidism, showing higher peak thyrotropin levels at diagnosis or at follow-up.

Conclusions Multiple IR, namely FCRL3 and TIGIT, but not the transcription factors HELIOS and FOXP3E2, showed increased mRNA levels in PB T cells from end-stage, long-standing and/or more aggressive AT, in proportion to disease severity. A relation with major clinical subphenotypes was observed, thereby identifying IR as potentially important players in AT.

Keywords

T-lymphocytes - gene expression - Hashimoto disease - costimulatory and inhibitory T-cell receptors - disease attributes - thyroid gland

^* Equally contributed authorship

• References

• 1 Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003; 348: 2646-2655
• 2 Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rec Immunol 2013; 13: 227-242
• 3 Bin Dhuban K, d'Hennezel E, Nashi E. et al. Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells. J Immunol 2015; 194: 3687-3696
• 4 Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rec Immunol 2015; 15: 486-499
• 5 Martinet L, Smyth MJ. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol 2015; 15: 243-254
• 6 Kurtulus S, Sakuishi K, Ngiow SF. et al. TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest 2015; 125: 4053-4062
• 7 Joller N, Lozano E, Burkett PR. et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014; 40: 569-581
• 8 Nagata S, Ise T, Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 2009; 182: 7518-7526
• 9 Bajpai UD, Swainson LA, Mold JE. et al. A functional variant in FCRL3 is associated with higher FcRL3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum 2012; 64: 2451-2459
• 10 Swainson LA, Mold JE, Bajpai UD. et al. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 2010; 184: 3639-3647
• 11 Kochi Y, Myouzen K, Yamada R. et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol 2009; 183: 5502-5510
• 12 Thornton AM, Korty PE, Tran DQ. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010; 184: 3433-3441
• 13 Takatori H, Kawashima H, Matsuki A. et al. Helios Enhances Treg Cell Function in Cooperation With FoxP3. Arthritis Rheumatol 2015; 67: 1491-1502
• 14 Nakagawa H, Sido JM, Reyes EE. et al. Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity. Proc Natl Acad Sci U S A. 2016; 113: 6248-6253
• 15 Zhang Y, Maksimovic J, Naselli G. et al. Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells. Blood 2013; 122: 2823-2836
• 16 De Rosa V, Galgani M, Porcellini A. et al. Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol 2015; 16: 1174-1184
• 17 Stefanic M, Papic S, Suver M. et al. Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. Int J Immunogenet 2008; 35: 125-131
• 18 Tokić S, Štefanić M, Glavaš-Obrovac L. et al. The expression of T cell FOXP3 and T-bet is upregulated in severe but not euthyroid Hashimoto's thyroiditis. Mediators Inflamm 2016; 2016; 3687420 doi:10.1155/2016/3687420
• 19 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
• 20 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
• 21 Fuertes Marraco SA, Neubert NJ, Verdeil G. et al. Inhibitory Receptors Beyond T Cell Exhaustion. Front Immunol 2015; 6: 310 doi:10.3389/fimmu.2015.00310
• 22 Lozano E, Dominguez-Villar M, Kuchroo V. et al. The TIGIT/CD226 axis regulates human T cell function. J Immunol 2012; 188: 3869-3875
• 23 Lozano E, Joller N, Cao Y. et al. The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti-inflammatory (Th2) balance in humans. J Immunol 2013; 191: 3673-3680
• 24 Liu S, Zhang H, Li M. et al. Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ 2013; 20: 456-464
• 25 Joller N, Hafler JP, Brynedal B. et al. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. J Immunol 2011; 186: 1338-1342
• 26 Hafler JP, Maier LM, Cooper JD. et al. International Multiple Sclerosis Genetics Consortium (IMSGC), Worthington J, Kuchroo VK, Wicker LS, Todd JA. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun 2009; 10: 5-10
• 27 Todd JA, Walker NM, Cooper JD. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-864
• 28 Chew GM, Fujita T, Webb GM. et al. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog 2016; 12: e1005349 doi:10.1371/journal.ppat.1005349
• 29 Ferreira R, Rainbow D, Rubio García A. et al. Human IL-6 R(hi)TIGIT(-) CD4(+)CD127(low)CD25(+) T cells display potent in vitro suppressive capacity and a distinct Th17 profile. Clin Immunol 2017; 179: 25-39
• 30 Luo Q, Deng Z, Xu C. et al. Elevated Expression of Immunoreceptor Tyrosine-Based Inhibitory Motif (TIGIT) on T Lymphocytes is Correlated with Disease Activity in Rheumatoid Arthritis. Med Sci Monit 2017; 23: 1232-1241
• 31 Mao L, Hou H, Wu S. et al. TIGIT signalling pathway negatively regulates CD4(+) T-cell responses in systemic lupus erythematosus. Immunology 2017; 151: 280-290
• 32 Zhao W, Dong Y, Wu C. et al. TIGIT overexpression diminishes the function of CD4 T cells and ameliorates the severity of rheumatoid arthritis in mouse models. Exp Cell Res 2016; 340: 132-138
• 33 Okajima M, Wada T, Nishida M. et al. Analysis of T cell receptor Vβ diversity in peripheral CD4+ and CD8+ T lymphocytes in patients with autoimmune thyroid diseases. Clin Exp Immunol 2009; 155: 166-172
• 34 Song Y, Wang B, Song R. et al. T-cell Immunoglobulin and ITIM Domain Contributes to CD8(+)T-cell Immunosenescence. Aging Cell 2018; 17 doi:
• 35 Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U. et al. Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients. Front Oncol 2017; 7: 53 doi:10.3389/fonc.2017.00053
• 36 McLeod DS, Watters KF, Carpenter AD. et al. Thyrotropin and thyroid cancer diagnosis: A systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 2012; 97: 2682-2692
• 37 Manieri NA, Chiang EY, Grogan JL. TIGIT: A Key Inhibitor of the Cancer Immunity Cycle. Trends Immunol 2017; 38: 20-28
• 38 Chu X, Pan CM, Zhao SX. et al. China Consortium for Genetics of Autoimmune Thyroid Disease. A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011; 43: 897-901
• 39 Simmonds MJ, Brand OJ, Barrett JC. et al. Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Clin Endocrinol (Oxf) 2010; 73: 654-660
• 40 Kochi Y, Yamada R, Suzuki A. et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37: 478-485
• 41 Zhao SX, Liu W, Zhan M. et al. China Consortium for the Genetics of Autoimmune Thyroid Disease. A refined study of FCRL genes from a genome-wide association study for Graves' disease. PLoS One 2013; 8: e57758 doi: 10.1371/journal.pone.0057758
• 42 Wu S, Cai T, Chen F. et al. Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population. Int J Clin Exp Med 2015; 8: 16948-16954
• 43 Gabrielsen IS, Amundsen SS, Helgeland H. et al. Genetic risk variants for autoimmune diseases that influence gene expression in thymus. Hum Mol Genet 2016; 25: 3117-3124
• 44 Jin G-X, Zhou Y-Y, Yu L. et al. Correlation between single nucleotide polymorphism of FCRL-3 gene and Graves’ disease in Han population of northern Anhui province, China. Int J. Clin Exp Med 2015; 8: 12624-12630
• 45 Brorsson CA, Onengut S, Chen WM. et al. Type 1 Diabetes Genetics Consortium. Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes. Diabetes 2015; 64: 3017-3027
• 46 Wojciechowska-Durczynska K, Krawczyk-Rusiecka K, Zygmunt A. et al. In children with autoimmune thyroiditis CTLA4 and FCRL3 genes—but not PTPN22-are overexpressed when compared to adults. Neuro Endocrinol Lett 2016; 37: 65-69
• 47 Akimova T, Beier UH, Wang L. et al. Helios expression is a marker of T cell activation and proliferation. PLoS One 2011; 6: e24226 doi:10.1371/journal.pone.0024226
• 48 Ferreira RC, Simons HZ, Thompson WS. et al. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity. J Autoimmun 2017; 84: 75-86
• 49 Lu L, Barbi J, Pan F. The regulation of immune tolerance by FOXP3. Nat Rev Immunol 2017; 17: 703-717
• 50 Kristensen B, Hegedüs L, Madsen HO. et al. Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto's thyroiditis. Clin Exp Immunol 2015; 180: 58-69